Labeled and non-label electrochemical peptide inhibitor-based biosensing platform for determination of hemopexin domain of matrix metalloproteinase-14.
Two labeled and non-label electrochemical peptide-based biosensors for highly sensitive and selective determination of hemopexin domain of matrix metalloproteinase-14 (PEX-14) were reported for the first time. Herein, the thiolated PEX-14 binding peptide inhibitor (ISC) or the ISC-tagged with ferrocene carboxylic acid (CIS-Fc) was self-assembled on the surface of gold electrode tested for binding with PEX-14 by non-label electrochemical impedance spectroscopy or labeled electrochemical (L-EC) transducers. The two biosensors were compared for the analytical performance of the detection of PEX-14 with detection limit of 0.3 pg mL-1 (for L-EC biosensor) and 0.03 ng mL-1 (for EIS biosensor). This work demonstrates that probing the PEX of MMPs represents a novel approach to assess MMPs-mediated cancer dissemination and provide a platform for screening the inhibitors of Matrix metalloproteinases.